Providers will find immediate opportunity to provide virtual visits to patients enrolled in Medicare plans as CMS seeks to facilitate screening and treatment of novel coronavirus (COVID-19) cases through telehealth services and implement billing guidance for these visits.
Providers in the U.S. will soon have a specific ICD-10-CM diagnosis code for the COVID-19 virus. During a March 18 meeting, The ICD-10 Coordination and Maintenance Committee announced that it would adopt the World Health Organization (WHO) code, U07.1 (COVID-19), effective April 1.
Previously, the panel had planned to implement the code beginning October 1 in the U.S. But the committee moved up the adoption date after the WHO declared COVID-19 a pandemic and President Trump declared the spread of the virus a national emergency, explained Donna Pickett, head of the diagnosis coding side of the ICD-10 Coordination and Maintenance Committee. She announced the April 1 implementation date during the March 18 committee meeting.
Prior to April 1, providers can continue to report based on previously published interim guidelines, which outline, among other things, how to report illnesses caused by COVID-19.
Note that code U07.1 should be reported only for confirmed cases. Providers should continue to follow the interim guidelines for unconfirmed cases of suspected exposure or symptoms.
Code U07.1 is designed to be a primary code—coders are advised to code also pneumonia and all other manifestations.
CMS announced blanket waivers of certain Medicare requirements to prevent gaps in care for beneficiaries affected by the novel coronavirus (COVID-19) public health emergency. The agency released billing instructions and a set of Q&As.
Q: Are disposable instrumentation tools, those typically used in endoscopic or cardiac procedures, considered integral to the procedure or are they separately chargeable?
